SCANORTO A/S: Financial statements 2024
CVR: 12687648
Source: annual report 2024, Danish Business Authority
01/01/2024 – 31/12/2024
SCANORTO A/S (CVR 12687648) has filed annual accounts for 2024. In 2024, the company reported a gross profit of DKK 12,777,070 and a net result of DKK 1,654,974 compared with DKK 1,455,641 the year before. That is a decrease of 19.2% compared with the year before. Equity in the 2024 report amounted to DKK 11,033,003. The solvency ratio was 30.8%. The company had 12 employees in the financial year.
- Gross Profit
- DKK 12,777,070
- Profit/Loss
- DKK 1,654,974
- Equity
- DKK 11,033,003
- Total Assets
- DKK 35,850,381
- Employees
- 12
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2024 | - | 12.8 mio. | 1.7 mio. | 11 mio. | 12 |
| 2023 | - | 15.8 mio. | 1.5 mio. | 9.4 mio. | 14 |
| 2022 | - | 14.7 mio. | 861 t. | 7.9 mio. | 13 |
| 2021 | - | 12.7 mio. | 532 t. | 7.1 mio. | 13 |
| 2020 | - | 6.7 mio. | 733 t. | 6.5 mio. | 10 |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2024
SCANORTO A/S has published its annual report for 2023. Gross profit came to DKK 15,818,693, and the net result was DKK 1,455,641.
As of March 13, 2024, Karel Budka has joined the board of directors of SCANORTO A/S.
As of March 13, 2024, Torben Nielsen has left the board of directors of SCANORTO A/S.
As of March 13, 2024, Maria Luisa Caggiula has left the board of directors of SCANORTO A/S.
About SCANORTO A/S
SCANORTO A/S is a Danish company of the type Aktieselskab based in Kgs. Lyngby, founded in 1989. The company is registered under the industry Engroshandel med læge- og hospitalsartikler. The company was previously named LASSE LAGER HOLDING ApS and ASX 14746 ApS. The management consists of Karel Rajchert. The board consists of Karel Budka (chair), Filipa Alexandra Pinto De Almeida and Karel Rajchert. The company is owned by NOBEL BIOCARE DANMARK A/S. The company has 12 employees (2026). In 2025, the company reported a gross profit of DKK 12,395,453 and a net result of DKK 1,917,702 compared with DKK 1,654,974 the year before. Equity in the 2025 report amounted to DKK 12,950,705.